KATALYTISCHE OLEFINISOMERISIERUNG VON 3-BOROLENEN; DER ERSTE ZUGANG ZU 2-BOROLENEN

DOI: 10.1016/S0022-328X(00)99214-3

Source and publish data:

Journal of Organometallic Chemistry p. C23 - C26 (1983)

Update date:2022-08-11

Topics:

Authors:

Herberich, G. E.

Hessner, B.

Soehnen, D.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0022-328X(00)99214-3

The first 2-borolenes (Ia: R=NPr2ⁱ, Ib: R=Ph) have been obtained by catalytic isomerization of the corresponding 3-borolenes (II). <(C2H4)2RhCl>2 is used as catalyst precursor and slowly forms inactive (borole)rhodium comp

Full text of DOI:10.1016/S0022-328X(00)99214-3

Products guided by the article

Product name:1H-Borole, 2,3-dihydro-1-phenyl-

Cas No:89377-15-1

R&D Labs maybe for 89377-15-1

Shanghai Gsyn Chemical Co.,Ltd.

Contact:86-021-67158290

Address:86-021-67158291
Simagchem Corporation

website:http://www.simagchem.com

Contact:+86-592-2680277

Address:21/F Hualong Office Building,No.6 Hubin East Road, Xiamen,China
Shaanxi King Stone Enterprise Company Limited

Contact:86-29-88353805,13609285751

Address:.209 Keji Road Hi-Tech industrial Develpment Zone .Xian China
Weifang Arylchem Chemical Co., LTD

Contact:86-536-5217866

Address:Development Zone, Shouguang, Shandong Province
Kraeber & Co GmbH

Contact:+49-4101-3053-0

Address:Waldhofstrasse 14 ,25474 Ellerbek Germany

Relevant to this article

Template-free solvothermal synthesis of size-controlled yttria-stabilized-zirconia hollow spheres

Doi:10.1016/j.jallcom.2011.06.111
(2011)
Iron(III) chloride catalyzed glycosylation of peracylated sugars with allyl/alkynyl alcohols

Doi:10.1590/S0103-50532012005000070
(2012)
Doi:10.1039/C19670000367
(1967)
Synthesis of Enantiopure 6,11-Methylene Lipoxin B₄ Methyl Ester

Doi:10.1002/ejoc.202001591
(2021)
Stable Boron Peroxides with a Subporphyrinato Ligand

Doi:10.1002/anie.201511590
(2016)
An improved method for the rapid preparation of 2-amino-4,4a-dihydro-4a,7-dimethyl-3H-phenoxazine-3-one, a novel antitumor agent

Doi:10.1016/S0960-894X(01)00153-6
(2001)

Article Doi